Fundz

Real-time funding, M&A, exec moves & hiring — the signals that move deals

More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.

The funding market, moving in real timeBook a DemoStart with Pro — $79/mo
Loading live signals…

Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.

Back to SEC Filings
Executive ChangeItem 5.02 · 8-KLOW RiskNeutral

CareDx, Inc.

Filed: Jun 11, 2026CIK: 0001217234
View on SEC.gov

AI Executive Summary

AI-powered analysis of 8-K filing content

CareDx stockholders approved an amendment to the 2024 Equity Incentive Plan on June 11, 2026, which was initially adopted by the Board on April 21, 2026. This amendment restructures executive and director compensation to better align incentives with long-term company objectives.

Key Takeaways

Stockholder approval obtained for 2024 Equity Incentive Plan amendment on June 11, 2026

Board of Directors initially adopted the amendment on April 21, 2026, contingent on stockholder approval

2 more takeaways

Filing Overview

Form Type8-K
Filing DateJun 11, 2026
Item5.02
CategoryExecutive Change
CIK0001217234
Accession #cdna-20260611
Risk LevelLOW
SentimentNeutral
Signalinformational
Topics
material agreement

What This Means

A senior executive (CEO, CFO, etc.) has joined, departed, or changed roles. Leadership changes can significantly impact strategy.
View Full Filing on SEC.govBrowse More Filings